@strypey I will step in and attempt to satisfy your curiosity about the term "transfection". Since I'm the one who first reached out to you i feel it would be dishonorable not to respond.
The so-called "vaccines" based on the mRNA platform are not a novel technology at all, but rather a permutation of an already existing transfection technology used in academic biology for the last two decades. The commercially available product lipofectamine has already been used in conjuction with mechanical agitation to create lipid nano particles onsite in labs around the world.
Likewise, recombinant RNA techniques in conjunction with their replication in cell culture (commonly referred to as "process 2") is a time tested process for creating large quantities of synthetic RNA molecules. The "novel" mRNA products are marketed as a new technology to circumvent patent law and provide cover for big pharmaceutical corporations to fraudulently reap massive profits from this previously existing intellectual property.
These products are also marketed as vaccines to cover up the fact that this technology of transfection has already been proven to be both useless as a therapy and dangerous in both animals and humans -- best exemplified by the jesse gelsinger case.